Table 1.

Quantified interest of prescribers in the different aspect of support and education regarding unlicensed cannabis-based medical products

Topic/segmentNew prescribersExperienced prescribers
Setup: registration to CDAO, guidelines creation, interaction with CQC, compliance audit.52
Education: training on endocannabinoid system, CBMPs legal status in the UK, existing products.52
Product: labelling, absorption method, terpenes profile, content, price, delivery and personalisation.44
Prescribing support: MDT, titration, dosage limit, patient eligibility, reminders.53
Admin: researching patient information, writing and mailing prescriptions, shared care management.34
Treatment tracking: patient scoring and scientifically validated questionnaires.35